Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells

Cellular Immunology

Volumn 259, Issue 2, 2009, Pages 135-140

  Qi, Chun Jian ^a   Qian, Ke Qing ^a   Ning, Yong Ling ^a   Ma, Hong Bing ^b   Wang, Shi Zhong ^a   Zhang, Xue Guang ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; CD40; Gastric cancer; VEGF

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; SMALL INTERFERING RNA; VASCULOTROPIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD40; APOPTOSIS; CD40 LIGAND; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; FLOW CYTOMETRY; HUMANS; INDOLES; MORPHOLINES; NUCLEAR PROTEINS; PROTEIN KINASE INHIBITORS; PYRROLES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349105941     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.06.007     Document Type: Article

References (34)

1. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., and Fujii H. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int. J. Cancer 122 (2008) 2286-2293
2. Panani A.D. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 266 (2008) 99-115
3. Schneider B.G., Camargo M.C., Ryckman K.K., Sicinschi L.A., Piazuelo M.B., Zabaleta J., Correa P., and Williams S.M. Cytokine polymorphisms and gastric cancer risk: an evolving view. Cancer Biol. Ther. 7 (2008) 157-162
4. Quezada S.A., Jarvinen L.Z., Lind E.F., and Noelle R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22 (2004) 307-328
5. Lougaris V., Badolato R., Ferrari S., and Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol. Rev. 203 (2005) 48-66
6. D'Orlando O., Gri G., Cattaruzzi G., Merluzzi S., Betto E., Gattei V., and Pucillo C. Outside inside signalling in CD40-mediated B cell activation. J. Biol. Regul. Homeost. Agents 21 (2007) 49-62
7. Ochs H.D., Hollenbaugh D., and Aruffo A. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency. Semin. Immunol. 6 (1994) 337-341
8. Vonderheide R.H. Prospect of targeting the CD40 pathway for cancer therapy. Clin. Cancer Res. 13 (2007) 1083-1088
9. Hollmann C.A., Owens T., Nalbantoglu J., Hudson T.J., and Sladek R. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death. Cancer Res. 66 (2006) 3550-3557
10. Liu A., Guardino A., Chinsangaram L., Goldstein M.J., Panicali D., and Levy R. Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand. Cancer Res. 67 (2007) 7037-7044
11. Wang S., Yang T., Zhu F., Zhu J., Huang Y., Wu L., Chen L., and Xu Z. CD40L-mediated inhibition of NF-kappaB in CA46 Burkitt lymphoma cells promotes apoptosis. Leuk. Lymphoma 49 (2008) 1792-1799
12. Gomes E.M., Rodrigues M.S., Phadke A.P., Butcher L.D., Starling C., Chen S., Chang D., Hernandez-Alcoceba R., Newman J.T., Stone M.J., and Tong A.W. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin. Cancer Res. 15 (2009) 1317-1325
13. Sabel M.S., Yamada M., Kawaguchi Y., Chen F.A., Takita H., and Bankert R.B. CD40 expression on human lung cancer correlates with metastatic spread. Cancer Immunol. Immunother. 49 (2000) 101-108
14. Lo S.S., Wu C.W., Chi C.W., Li A.F., Chen J.H., and Lui W.Y. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis. Hepatogastroenterology 52 (2005) 1902-1904
15. Cooke P.W., James N.D., Ganesan R., Wallace M., Burton A., and Young L.S. CD40 expression in bladder cancer. J. Pathol. 188 (1999) 38-43
16. Bereznaya N.M., Kirnasovskaya E.A., Vinnichuk Y.D., Belova O.B., and Lukyanova N.Y. Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors. Exp. Oncol. 30 (2008) 295-299
17. Bereznaya N.M., and Chekhun V.F. Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy. Exp. Oncol. 29 (2007) 2-12
18. Murugaiyan G., Martin S., and Saha B. CD40-induced countercurrent conduits for tumor escape or elimination?. Trends Immunol. 28 (2007) 467-473
19. Farahani M., Treweeke A.T., Toh C.H., Till K.J., Harris R.J., Cawley J.C., Zuzel M., and Chen H. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells. Leukemia 19 (2005) 524-530
20. Dormond O., Contreras A.G., Meijer E., Datta D., Flynn E., Pal S., and Briscoe D.M. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. J. Immunol. 181 (2008) 8088-8095
21. Deregibus M.C., Buttiglieri S., Russo S., Bussolati B., and Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 278 (2003) 18008-18014
22. Shafee N., Kaluz S., Ru N., and Stanbridge E.J. PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett. 282 (2009) 109-115
23. Zhou Z.H., Wang J.F., Wang Y.D., Qiu Y.H., Pan J.Z., Xie W., Jiang L.Y., Klein B., and Zhang X.G. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line. Hybridoma 18 (1999) 471-478
24. Tomeczkowski J., Beilken A., Frick D., Wieland B., Konig A., Falk M.H., Reiter A., Welte K., and Sykora K.W. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood 86 (1995) 1469-1480
25. Yin F., Bruemmer D., Blaschke F., Hsueh W.A., Law R.E., and Herle A.J. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene 23 (2004) 4614-4623
26. Santos S.C., and Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 103 (2004) 3883-3889
27. Yuan T.L., Choi H.S., Matsui A., Benes C., Lifshits E., Luo J., Frangioni J.V., and Cantley L.C. Class 1A PI3K regulates vessel integrity during development and tumorigenesis. Proc. Natl. Acad. Sci. USA 105 (2008) 9739-9744
28. Schnell C.R., Stauffer F., Allegrini P.R., O'Reilly T., McSheehy P.M., Dartois C., Stumm M., Cozens R., Littlewood-Evans A., Garcia-Echeverria C., and Maira S.M. Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging. Cancer Res. 68 (2008) 6598-6607
29. Edelmann J., Klein-Hitpass L., Carpinteiro A., Fuhrer A., Sellmann L., Stilgenbauer S., Duhrsen U., and Durig J. Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk. Res. 32 (2008) 1565-1572
30. Kang J., Rychahou P.G., Ishola T.A., Mourot J.M., Evers B.M., and Chung D.H. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene 27 (2008) 3999-4007
31. Fang J., Ding M., Yang L., Liu L.Z., and Jiang B.H. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal. 19 (2007) 2487-2497
32. Higashi H., Vallbohmer D., Warnecke-Eberz U., Hokita S., Xi H., Brabender J., Metzger R., Baldus S.E., Natsugoe S., Aikou T., Holscher A.H., and Schneider P.M. Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer. Anticancer Res. 26 (2006) 2143-2147
33. Qi C.J., Zheng L., Zhou X., Tao Y., Ge Y., Zhuang Y.M., Xu Y., Yu G., and Zhang X.G. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells. Immunol. Lett. 93 (2004) 151-158
34. Chen Y., Chen J., Xiong Y., Da Q., Xu Y., Jiang X., and Tang H. Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem. Biophys. Res. Commun. 345 (2006) 106-117